Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
- 16 January 1998
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 279 (5349), 377-380
- https://doi.org/10.1126/science.279.5349.377
Abstract
In vivo selection of phage display libraries was used to isolate peptides that home specifically to tumor blood vessels. When coupled to the anticancer drug doxorubicin, two of these peptides—one containing an αv integrin–binding Arg-Gly-Asp motif and the other an Asn-Gly-Arg motif—enhanced the efficacy of the drug against human breast cancer xenografts in nude mice and also reduced its toxicity. These results indicate that it may be possible to develop targeted chemotherapy strategies that are based on selective expression of receptors in tumor vasculature.Keywords
This publication has 33 references indexed in Scilit:
- Addressing tumor blood vesselsNature Biotechnology, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Organ targeting In vivo using phage display peptide librariesNature, 1996
- VasculogenesisAnnual Review of Cell and Developmental Biology, 1995
- Peptide Ligands for Integrin .alpha.v.beta.3 Selected from Random Phage Display LibrariesBiochemistry, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Penetration of Tumor Tissue by Antibodies and Other ImmunoproteinsAnnals of the New York Academy of Sciences, 1991
- Tumor interactions with the vasculature: angiogenesis and tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- Fate of Bacteriophage Lambda in Non-immune Germ-free MiceNature, 1973